This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Siemens Medical Solutions USA, Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Verena Hugenberg - Innovator in Matrix Metalloproteinase Research
Introduction
Verena Hugenberg is a distinguished inventor based in Bersenbrueck, Germany. She has made significant contributions to the field of pharmaceutical sciences, particularly in the study and development of compounds targeting matrix metalloproteinases (MMPs). Her innovative work focuses on creating novel compounds that hold great promise for the prevention and treatment of various diseases.
Latest Patents
Verena Hugenberg holds one patent titled "Compounds with matrix-metalloproteinase inhibitory activity and imaging agents thereof." This patent discloses novel compounds and pharmaceutical compositions that exhibit MMP inhibitory activity. These compounds are particularly useful in the prevention, treatment, and diagnostic imaging of diseases linked to unpaired MMP activity, including MMP-2, MMP-8, MMP-9, and MMP-13. The applications of these compounds extend to a variety of disease states, including inflammatory, malignant, and degenerative diseases where specific matrix metalloproteinases are implicated.
Career Highlights
Verena currently works at Siemens Medical Solutions USA, Inc., where she applies her expertise in pharmaceutical development to advance healthcare solutions. Her pioneering research has helped position her as a key inventor in her field, contributing to important advancements in medical treatments and diagnostic tools.
Collaborations
Throughout her career, Verena has collaborated with notable colleagues such as Gang Chen and Umesh B Gangadharmath. These collaborations underscore the importance of teamwork in fostering innovation and advancing research endeavors within the medical and pharmaceutical domains.
Conclusion
Verena Hugenberg stands out as a notable figure in the innovation landscape, with her patent-driven work contributing to the understanding and treatment of diseases through matrix metalloproteinase inhibition. Her ongoing efforts at Siemens Medical Solutions USA, Inc. illustrate her commitment to leveraging science for the betterment of healthcare solutions, and her collaborations pave the way for further advancements in the field.